Azome data presented at Hyaluronan 2023

June 8, 2023

Rashmin Savani, MBChB, Head of Scientific Advisory Board, Azome Therapeutics, presented results of preclinical research supporting the company’s RHAMM (Receptor for Hyaluronan-Mediated Motility) antagonist technology platform at the 14th conference of the International Society for Hyaluronan Sciences held this week in Portland, Oregon.